A patient with a history of type 2 diabetes and hypertension presents with pronounced jaundice, confusion, and elevated liver enzymes. What is the priority nursing intervention to prevent the progression of hepatic encephalopathy in this patient?

A) Administer lactulose as prescribed to reduce ammonia levels

B) Encourage a high-protein diet to support liver function

C) Restrict fluid intake to prevent ascites formation

D) Administer diuretics to manage potential fluid overload

A patient with a history of type 2 diabetes, hypertension, and suspected non-alcoholic steatohepatitis (NASH) is exhibiting signs of hepatic encephalopathy. Which nursing intervention is a priority to help prevent further complications related to liver dysfunction?

B) Administer lactulose as prescribed to reduce ammonia levels.

A) Encourage a high-protein diet to support liver regeneration.

B) Administer lactulose as prescribed to reduce ammonia levels.

C) Increase physical activity to improve overall metabolic health.

D) Restrict fluid intake to prevent ascites formation.

A patient with worsening hepatic encephalopathy and suspected sepsis is being treated with lactulose and broad-spectrum antibiotics. Which nursing intervention is the highest priority to address her current condition?

A) Monitor the patient's blood pressure closely and administer intravenous fluids as prescribed.

B) Assess the patient's neurological status every 2 hours to evaluate response to lactulose.

C) Obtain blood cultures before administering antibiotics to identify the causative organism.

D) Monitor for signs of bleeding and review coagulation studies regularly due to increased INR.

A patient with worsening hepatic encephalopathy is exhibiting confusion, disorientation, and elevated ammonia levels. The nurse understands that which of the following interventions is most appropriate to help lower the ammonia levels?

A) Administering lactulose as prescribed

B) Increasing dietary protein intake

C) Providing a high-calorie, high-carbohydrate diet

D) Reducing fluid intake to prevent ascites

A patient with severe hepatic encephalopathy and suspected septic shock presents with persistent lethargy, asterixis, and hypotension unresponsive to intravenous fluids. Considering the patient's condition, which of the following interventions should the nurse prioritize to address the underlying issues?

C) Initiate broad-spectrum antibiotics to target potential sepsis.

A) Increase the dose of lactulose to enhance ammonia clearance.

B) Prepare for the administration of vasopressors to manage hypotension.

C) Initiate broad-spectrum antibiotics to target potential sepsis.

D) Administer fresh frozen plasma to correct coagulopathy.

A patient with severe hepatic encephalopathy and suspected septic shock is being managed in the ICU. Despite lactulose therapy, she shows no significant neurological improvement, and her blood pressure is 95/58 mmHg with a heart rate of 115 beats per minute. Which of the following actions should the nurse prioritize to address the patient's current clinical status?

A) Administer vasopressors to stabilize the patient's blood pressure.

B) Increase the dose of lactulose to enhance ammonia clearance.

C) Administer supplemental oxygen to improve oxygen saturation.

D) Prepare for the administration of fresh frozen plasma to manage coagulopathy.

A patient with an intra-abdominal infection is being treated with intravenous ceftriaxone for Escherichia coli. Despite the antimicrobial therapy, the patient remains hemodynamically unstable with a blood pressure of 90/56 mmHg and a heart rate of 120 beats per minute. What is the nurse's priority intervention to ensure adequate organ perfusion?

B) Administer norepinephrine to maintain mean arterial pressure

A) Increase the rate of intravenous fluids

B) Administer norepinephrine to maintain mean arterial pressure

C) Reassess the need for supplemental oxygen

D) Prepare for administration of fresh frozen plasma

A patient with a liver abscess caused by Escherichia coli is experiencing hemodynamic instability despite aggressive fluid resuscitation. Blood pressure is 90/56 mmHg, heart rate is 120 bpm, and mean arterial pressure needs to be maintained above 65 mmHg. Norepinephrine infusion has been initiated. Which nursing intervention is most critical in the immediate care of this patient?

A) Monitor for signs of norepinephrine extravasation at the IV site.

B) Increase the rate of fluid resuscitation to raise blood pressure.

C) Administer fresh frozen plasma to correct the INR of 2.4.

D) Start continuous renal replacement therapy to manage potential renal failure.

A patient in septic shock with suspected hepatic encephalopathy is being treated with norepinephrine, vasopressin, and lactulose. Despite these interventions, the patient's mean arterial pressure remains low, and their mental status continues to decline. New laboratory results indicate a drop in platelet count to 75,000/µL, suggesting disseminated intravascular coagulation (DIC). What is the most appropriate nursing intervention to prioritize at this time?

C) Prepare for the administration of blood products to address coagulopathy.

A) Increase the dose of norepinephrine to maintain adequate blood pressure.

B) Administer lactulose more frequently to enhance ammonia excretion.

C) Prepare for the administration of blood products to address coagulopathy.

D) Initiate a continuous EEG to monitor for seizure activity due to hepatic encephalopathy.

A patient with septic shock and suspected disseminated intravascular coagulation (DIC) is being managed with norepinephrine, vasopressin, and fluid resuscitation. The patient's ammonia level is 120 µmol/L, and lactulose therapy has been initiated. Which nursing intervention is most critical to prevent further complications related to the patient's condition?

A) Monitor the patient for signs of bleeding and administer blood products as ordered.

B) Frequently assess neurological status and report any changes immediately.

C) Maintain strict intake and output records to monitor for fluid overload.

D) Administer antibiotics as scheduled to address the underlying infection.

hepatitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatitis involves inflammation of the liver, primarily caused by viral infections (e.g., Hepatitis A, B, C) or non-viral factors like alcohol and toxins. The immune response to these pathogens or toxins leads to hepatocyte injury and necrosis.

• Secondary mechanism: As inflammation progresses, the liver's ability to process bilirubin is compromised, resulting in jaundice. Additionally, the immune-mediated attack and subsequent fibrosis can disrupt normal liver architecture and function, leading to potential cirrhosis over time.

• Key complication: Chronic hepatitis can result in liver fibrosis and cirrhosis, impairing liver function critically. This may lead to portal hypertension, increased risk of liver cancer, and liver failure, highlighting the importance of early diagnosis and management.

Patient Profile

Demographics:

47-year-old female, school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Lisinopril 10 mg daily, Metformin 500 mg twice daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent fatigue and jaundice

• Key symptoms: Abdominal pain, nausea, dark urine, pale stools, mild confusion

• Vital signs: Temperature 101.3°F, Heart rate 110 bpm, Blood pressure 138/90 mmHg, Respiratory rate 20 breaths per minute, Oxygen saturation 94% on room air

Section 1

During the initial assessment, the nursing team noted several concerning findings that required immediate attention and further investigation. The patient's jaundice was pronounced, and her sclera was visibly yellow. Palpation of the abdomen revealed mild tenderness in the right upper quadrant, which was consistent with liver inflammation. Additionally, the patient's mild confusion raised concerns about hepatic encephalopathy, a condition that can occur when the liver fails to adequately filter toxins from the blood.

Laboratory results returned with significant abnormalities. Liver function tests showed elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating active liver inflammation. Bilirubin levels were significantly elevated, correlating with the patient's jaundice. An ultrasound of the abdomen revealed an enlarged liver with heterogeneous echotexture, suggesting possible fibrosis. These findings pointed towards a progression of liver disease, possibly transitioning towards cirrhotic changes, which could explain the patient's confusion and fatigue due to the impaired detoxification capabilities of her liver.

With these results, the clinical team prioritized stabilizing the patient while determining the underlying cause of her hepatitis. Given her history of type 2 diabetes and hypertension, the team considered the possibility of non-alcoholic steatohepatitis (NASH). However, viral hepatitis serologies were also ordered to rule out viral causes. The focus now shifted to managing symptoms and preventing further complications, such as controlling her blood glucose levels to reduce further hepatic stress and ensuring close monitoring for signs of worsening hepatic encephalopathy or developing portal hypertension. Implementing these measures would be critical in improving her clinical status and preventing the development of more severe complications.

Section 2

As the clinical team continued to monitor the patient, her condition began to exhibit new complications that required prompt intervention. The patient's mental status deteriorated further; she became increasingly confused and disoriented, indicating a potential worsening of hepatic encephalopathy. Vital signs showed a low-grade fever of 100.4°F, and her blood pressure dropped to 100/60 mmHg, raising concerns about systemic infection or sepsis, possibly due to bacterial translocation associated with portal hypertension. Her heart rate was elevated at 110 beats per minute, suggesting compensatory tachycardia in response to the hypotension or fever.

The latest laboratory results revealed a further increase in ammonia levels, supporting the hypothesis of worsening hepatic encephalopathy. Additionally, a complete blood count showed leukocytosis, with a white blood cell count of 15,000/µL, hinting at a potential infectious process. The patient's coagulation profile indicated an increased international normalized ratio (INR) of 2.0, reflecting impaired synthetic function of the liver and raising the risk for bleeding complications. These findings prompted the team to initiate lactulose therapy to reduce ammonia levels and consider broad-spectrum antibiotics to address the suspected infection.

Given the new complications, the clinical team prioritized a multi-faceted approach to stabilize the patient. This included adjusting her medication regimen to manage hepatic encephalopathy, monitoring her closely for signs of bleeding due to coagulopathy, and ensuring her hemodynamic stability with intravenous fluids. The team also planned to conduct further imaging studies, such as a CT scan of the abdomen, to assess for any signs of intra-abdominal abscess or other sources of infection. These interventions aimed to address the immediate concerns while preventing further deterioration, guiding the patient towards stabilization and recovery.

Section 3

As the clinical team continued their vigilant monitoring, the patient exhibited a change in her status that required immediate attention. Despite the initiation of lactulose therapy, the patient's neurological condition did not show significant improvement. Her disorientation persisted, and she began to exhibit asterixis, a hallmark of severe hepatic encephalopathy. The nursing staff noted that she was increasingly lethargic, with periods of unresponsiveness, prompting a reassessment of her treatment plan to ensure adequate ammonia clearance.

In parallel, the patient's hemodynamic profile showed further instability. Her blood pressure continued to trend downward, now at 95/58 mmHg, despite the administration of intravenous fluids. This hypotensive state, combined with an elevated heart rate that had risen to 115 beats per minute, suggested that the patient might be in a state of septic shock. Concurrently, the patient's oxygen saturation decreased to 92% on room air, necessitating supplemental oxygen to maintain adequate tissue perfusion. The team recognized the urgency in addressing potential sepsis, emphasizing the importance of optimizing antibiotic therapy and considering the potential need for vasopressors to stabilize her cardiovascular status.

While awaiting the results of the abdominal CT scan, which could provide further insights into the suspected intra-abdominal infection, the clinical focus shifted to meticulous monitoring for signs of bleeding, given the patient's elevated INR. The presence of petechiae on her extremities and mild oozing from recent venipuncture sites underscored the delicate balance required in managing her coagulopathy. The team deliberated the possibility of administering fresh frozen plasma to mitigate bleeding risks, alongside ongoing supportive measures. These observations and interventions highlighted the interconnected complexities of her condition, necessitating a cohesive and dynamic approach to her critical care management.

Section 4

As the clinical team continued their efforts to stabilize the patient, new diagnostic results from the abdominal CT scan arrived, revealing the presence of an abscess in the right lobe of the liver. This finding confirmed the suspicion of intra-abdominal infection as a contributing factor to the patient's deteriorating condition. The abscess, likely a result of bacterial translocation and impaired hepatic function, underscored the need for targeted antimicrobial therapy. Blood cultures obtained prior to antibiotic initiation had since returned, identifying Escherichia coli as the causative organism, guiding the team to adjust the antibiotic regimen to include a more specific coverage with intravenous ceftriaxone.

In conjunction with the adjustment of antibiotics, the clinical team faced the challenge of managing the patient's ongoing hemodynamic instability. Despite aggressive fluid resuscitation, her blood pressure remained at 90/56 mmHg with a heart rate of 120 beats per minute, reinforcing the need for vasopressor support. Norepinephrine infusion was initiated to maintain her mean arterial pressure above 65 mmHg, critical for ensuring adequate organ perfusion. The patient's oxygen saturation improved to 95% with supplemental oxygen, but her respiratory status continued to warrant close observation due to the risk of respiratory failure secondary to her hepatic encephalopathy and potential sepsis-related complications.

Amidst these developments, the patient's liver function tests showed a concerning trend, with bilirubin levels rising to 8.5 mg/dL and AST and ALT continuing to climb, now at 320 U/L and 280 U/L, respectively. These lab values, coupled with her worsening coagulopathy and INR of 2.4, highlighted the progressive hepatic dysfunction and the potential for further complications such as disseminated intravascular coagulation (DIC). The team prioritized frequent monitoring of her coagulation status and prepared for the administration of fresh frozen plasma to address the bleeding risks, aiming to stabilize her condition while awaiting further therapeutic response.

Section 5

As the clinical team continued its vigilant monitoring, a notable change in the patient's status emerged. Despite the initiation of norepinephrine and fluid resuscitation, the patient's hemodynamic parameters remained precarious. Her mean arterial pressure barely hovered around 65 mmHg, and her heart rate increased to 130 beats per minute, signaling a potential exacerbation of septic shock. The patient's systemic response suggested that additional support might be necessary to counteract her persistent circulatory dysfunction. Concurrently, her mental status deteriorated further, with increased confusion and lethargy, raising concerns about worsening hepatic encephalopathy.

In response to these developments, the team decided to escalate vasopressor therapy by adding vasopressin to the regimen, aiming to optimize hemodynamic stability. Simultaneously, they implemented strategies to address the patient's evolving complications. The decision was made to initiate lactulose therapy to manage hepatic encephalopathy, targeting the reduction of ammonia levels, which had surged to 120 µmol/L. The nursing staff monitored the patient closely for changes in neurological status, emphasizing the importance of frequent assessments to gauge the effectiveness of interventions and prevent further decline.

Further complicating the patient's clinical picture, new laboratory results revealed a drop in platelet count to 75,000/µL, heightening the suspicion of disseminated intravascular coagulation (DIC). The clinical team swiftly adjusted their management plan, preparing for the administration of additional blood products, including platelets and cryoprecipitate, to mitigate bleeding risks. These measures were critical as they balanced the dual challenges of supporting the patient's hemodynamics and addressing the burgeoning complications associated with her hepatic dysfunction and sepsis-related coagulopathy. As they navigated this complex clinical scenario, the team remained vigilant, anticipating further developments and maintaining readiness to adapt their strategies accordingly.